Article Dans Une Revue BONE Année : 2025

Teriparatide administration is osteoanabolic but does not impact atherosclerotic plaque calcification and progression in a mouse model of menopause.

Dates et versions

hal-05233746 , version 1 (01-09-2025)

Identifiants

Citer

Laurence Bessueille, Anne Briolay, Nicolas Guillot, Saïda Mebarek, Solène Viallon, et al.. Teriparatide administration is osteoanabolic but does not impact atherosclerotic plaque calcification and progression in a mouse model of menopause.. BONE, 2025, 190, pp.117316. ⟨10.1016/j.bone.2024.117316⟩. ⟨hal-05233746⟩
80 Consultations
0 Téléchargements

Altmetric

Partager

  • More